OBJECTIVE: The aim of the study was to assess the long-term results of a selective policy toward pulmonary valve replacement in adult patients with repaired tetralogy of Fallot and severe pulmonary regurgitation. METHODS: Sixty-seven patients with tetralogy of Fallot were followed up from 15 +/- 3 years until 27 +/- 3 years after surgery. RESULTS: Twenty-two patients had mild-to-moderate pulmonary regurgitation. No significant changes occurred in the follow-up period. Of 45 patients with severe pulmonary regurgitation and severe right ventricular dilatation, 28 (62%) remained free of symptoms and did not undergo pulmonary valve replacement. No changes in right ventricular size or exercise capacity were found. In 3 (11%) of 28 patients, QRS duration increased to more than 180 ms. Seventeen patients had symptoms and underwent pulmonary valve replacement: 9 (54%) of 17 patients improved clinically and echocardiographically, and QRS duration shortened postoperatively. Right ventricular dimensions did not regress despite pulmonary valve replacement in 8 patients. CONCLUSION: Refraining from pulmonary valve replacement in asymptomatic patients led to no measurable deterioration in 25 (89%) of 28 patients. Referring symptomatic patients for pulmonary valve replacement led to an improvement in 9 (53%) of 17 patients. In 11 (24%) of 45, a selective approach led to questionable or unsatisfactory results.
OBJECTIVE: The aim of the study was to assess the long-term results of a selective policy toward pulmonary valve replacement in adult patients with repaired tetralogy of Fallot and severe pulmonary regurgitation. METHODS: Sixty-seven patients with tetralogy of Fallot were followed up from 15 +/- 3 years until 27 +/- 3 years after surgery. RESULTS: Twenty-two patients had mild-to-moderate pulmonary regurgitation. No significant changes occurred in the follow-up period. Of 45 patients with severe pulmonary regurgitation and severe right ventricular dilatation, 28 (62%) remained free of symptoms and did not undergo pulmonary valve replacement. No changes in right ventricular size or exercise capacity were found. In 3 (11%) of 28 patients, QRS duration increased to more than 180 ms. Seventeen patients had symptoms and underwent pulmonary valve replacement: 9 (54%) of 17 patients improved clinically and echocardiographically, and QRS duration shortened postoperatively. Right ventricular dimensions did not regress despite pulmonary valve replacement in 8 patients. CONCLUSION: Refraining from pulmonary valve replacement in asymptomatic patients led to no measurable deterioration in 25 (89%) of 28 patients. Referring symptomatic patients for pulmonary valve replacement led to an improvement in 9 (53%) of 17 patients. In 11 (24%) of 45, a selective approach led to questionable or unsatisfactory results.
Authors: Tal Geva; Kimberlee Gauvreau; Andrew J Powell; Frank Cecchin; Jonathan Rhodes; Judith Geva; Pedro del Nido Journal: Circulation Date: 2010-09-14 Impact factor: 29.690
Authors: Dalin Tang; Chun Yang; Pedro J Del Nido; Heng Zuo; Rahul H Rathod; Xueying Huang; Vasu Gooty; Alexander Tang; Kristen L Billiar; Zheyang Wu; Tal Geva Journal: J Thorac Cardiovasc Surg Date: 2015-10-03 Impact factor: 5.209
Authors: Jamie L R Romeo; Johanna J M Takkenberg; Judith A A E Cuypers; Natasha M S de Groot; Pieter van de Woestijne; Nico Bruining; Ad J J C Bogers; M Mostafa Mokhles Journal: Eur J Cardiothorac Surg Date: 2020-09-01 Impact factor: 4.191
Authors: Daniel J Bowen; An M van Berendoncks; Jackie S McGhie; Jolien W Roos-Hesselink; Annemien E van den Bosch Journal: Int J Cardiovasc Imaging Date: 2021-05-18 Impact factor: 2.357